Mortality of Aeromonas Infections: A Systematic Review and Meta-Analysis

Despite the growing recognition of Aeromonas as a clinically important pathogen, significant heterogeneity exists in reported mortality rates across different patient populations and geographic regions. This wide variance and lack of consensus make it exceedingly difficult for infectious disease clinicians and public health authorities to accurately stratify patient risk, establish reliable prognostic benchmarks, and allocate healthcare interventions effectively. To date, there has been no comprehensive, globally synthesized data effort to establish a definitive, overarching baseline for Aeromonas-attributable mortality. Therefore, the primary objective of this systematic review and meta-analysis is to rigorously aggregate and quantify the global pooled mortality rate of laboratory-confirmed Aeromonas infections across different clinical presentations.